DUOXA2 and cyclic hematopoiesis: Both DUOX2 and DUOXA2 mutations may be associated with borderline TSH elevation on neonatal screening followed by a delayed TSH rise and profoundly subnormal FT4 level, resulting in CH which is severe, albeit transient (27).